Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Terminated1
Other2

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sparrow Regional Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mohamad A. Hussein, MD

The Cleveland Clinic

Related
8 trials

Shared therapeutic areas:

Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Collaborated on 1 trial
Similarity Score24%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma
Similarity Score20%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score20%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma
Similarity Score20%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00124579Phase 2PrincipalInvestigator

S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Terminated
NCT00389701Phase 2StudyChair

Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment

Multiple Myeloma and Plasma Cell Neoplasm
Unknown
NCT00723658Phase 2StudyChair

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

Lymphoma
Withdrawn

All 3 trials loaded